Vertex Pharmaceuticals Inc. buy EPG2026
Start price
27.01.13
/
50%
€34.73
Target price
19.04.13
€40.00
Performance (%)
85.13%
End price
19.04.13
€64.30
Summary
This prediction ended on 19.04.13 with a price of €64.30. The BUY prediction by EPG2026 for Vertex Pharmaceuticals Inc. saw massive gains of 85.13%. EPG2026 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Vertex Pharmaceuticals Inc. | 1.444% | 1.444% | 40.291% | 165.970% |
iShares Core DAX® | -0.612% | 0.567% | 12.585% | 14.838% |
iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% | 38.328% |
iShares Nikkei 225® | -2.647% | 0.330% | 9.482% | 5.652% |
iShares S&P 500 | -1.932% | -1.126% | 23.191% | 38.791% |
Comments by EPG2026 for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Sehr gute Biotechaktie
Vertex Pharma hat gute Produkte in der Pipeline
(Vom Mitglied beendet)